Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Guizhou Xinbang Pharmaceutical Co Ltd
Research & Development
Guizhou Xinbang Pharmaceutical Co Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
|
Research & Development
-¥4.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Research & Development
-¥2.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Research & Development
-¥228.3m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Research & Development
-¥5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Research & Development
-¥329.2m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Research & Development
-¥712.5m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Guizhou Xinbang Pharmaceutical Co Ltd's Research & Development?
Research & Development
-4.8m
CNY
Based on the financial report for Mar 31, 2024, Guizhou Xinbang Pharmaceutical Co Ltd's Research & Development amounts to -4.8m CNY.
What is Guizhou Xinbang Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
32%
Over the last year, the Research & Development growth was -175%. The average annual Research & Development growth rates for Guizhou Xinbang Pharmaceutical Co Ltd have been -19% over the past three years , 32% over the past five years .